Patrick J. Flynn's Insider Trades & SAST Disclosures
Patrick J. Flynn's most recent trade in NRX Pharmaceuticals Inc was a trade of 2,500 Common Stock, par value $0.001 per share done at an average price of $1.3 . Disclosure was reported to the exchange on Nov. 28, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick J. Flynn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 28 Nov 2022 | 2,500 | 37,709 | - | 1.3 | 3,125 | Common Stock, par value $0.001 per share |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 28 Nov 2022 | 2,500 | 40,209 | - | 1.2 | 3,100 | Common Stock, par value $0.001 per share |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 28 Nov 2022 | 2,500 | 37,709 | - | 1.3 | 3,125 | Common Stock, par value $0.001 per share |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 28 Nov 2022 | 2,500 | 40,209 | - | 1.3 | 3,125 | Common Stock, par value $0.001 per share |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 28 Nov 2022 | 1,750 | 1,750 | - | 1.3 | 2,188 | Common Stock, par value $0.001 per share |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 162,660 | 162,660 | - | - | Employee Stock Option | |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 692,639 | 692,639 | - | - | Common Stock Warrant (Right to buy) | |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 692,639 | 692,639 | - | - | Common Stock Warrant (Right to buy) | |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 362,332 | 362,332 | - | - | Common Stock | |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 35,209 | 35,209 | - | - | Common Stock | |
| NRX Pharmaceuticals Inc | Patrick J. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 35,209 | 35,209 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges